Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
Curr Drug Targets. 2022;23(14):1304-1318. doi: 10.2174/1389450123666220826160123.
Elabela, a bioactive micropeptide, is recognized as the second endogenous ligand for the Apelin receptor and is widely distributed in different tissues and organs. Elabela plays an important role in various physiological processes, such as blood pressure control, heart morphogenesis, apoptosis, angiogenesis, cell proliferation, migration, etc. Elabela is also implicated in pathological conditions, like cardiac dysfunctions, heart failure, hypertension, kidney diseases, cancer and CNS disorders. The association of Elabela with these disease conditions makes it a potential target for their therapy. This review summarizes the physiological role of Elabela peptide as well as its implication in various disease conditions.
埃拉贝拉(Elabela)是一种生物活性的微肽,被认为是 Apelin 受体的第二个内源性配体,广泛分布于不同的组织和器官中。埃拉贝拉在各种生理过程中发挥着重要作用,如血压控制、心脏形态发生、细胞凋亡、血管生成、细胞增殖、迁移等。埃拉贝拉还与一些病理状况有关,如心脏功能障碍、心力衰竭、高血压、肾脏疾病、癌症和中枢神经系统疾病。埃拉贝拉与这些疾病状况的关联使其成为治疗这些疾病的潜在靶点。本文综述了埃拉贝拉肽的生理作用及其在各种疾病中的意义。